Bindong Liu to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Bindong Liu has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
1.141
-
Tang RN, Lv LL, Zhang JD, Dai HY, Li Q, Zheng M, Ni J, Ma KL, Liu BC. Effects of angiotensin II receptor blocker on myocardial endothelial-to-mesenchymal transition in diabetic rats. Int J Cardiol. 2013 Jan 10; 162(2):92-9.
Score: 0.390
-
Dai HY, Zheng M, Tang RN, Ni J, Ma KL, Li Q, Liu BC. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. Am J Med Sci. 2011 Mar; 341(3):207-14.
Score: 0.382
-
Liu BC, Xia HL, Wu JN, Zhang XL, Liu DG, Gong YX. Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction. Acta Pharmacol Sin. 2007 Nov; 28(11):1810-8.
Score: 0.303
-
Liu BC, Chen L, Sun J, Huang HQ, Ma KL, Liu H, Liu DG, Zhang XL. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells. Nephron Exp Nephrol. 2006; 103(1):e16-26.
Score: 0.067